Related Experiment Video
Updated: Jun 4, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Effects of maneb on testosterone release in male rats
Faustin P Tsagué Manfo1, Wen-Fang Chao, Paul F Moundipa
1Laboratory of Pharmacology and Toxicology, Department of Biochemistry, Faculty of Science, University of Yaoundé, Cameroon. faustinpascal@yahoo.fr
Abstract:
Maneb (Manganese ethylene-bis-dithiocarbamate) is a widely used fungicide in agriculture. In order to investigate its effect on male reproductive function, rats were intraperitonealy injected with maneb (1 and 4 mg/kg) for 9 or 18 days. After 6 and 14 days of treatment, the animals received human chorionic gonadotropin (hCG) via a jugular catheter and blood samples were collected at several intervals subsequent to the challenge. They were thereafter decapitated after 9 or 18 days, and organs (i.e., liver, seminal vesicles, and kidneys) were weighed. Leydig cells prepared from rats after 18 days of treatment were incubated with or without different stimulators or precursors [hCG, A23187, 25-OH-cholesterol (25-OH-C), or androstenedione] for 1 hour, and the media were analyzed for testosterone or pregnenolone. Liver glutathione and thiobarbituric acid reactive substances (TBARS) as well as serum alanine aminotransferase (ALT) activity were also measured. Further, Leydig cells and testicular interstitial cells (TICs) prepared from normal rats were incubated with maneb (3-100 µM) for 1 or 2 hours, and testosterone release was assessed. The results showed that administration of maneb (4 mg/kg) for 9 and 18 days did not alter liver function, but resulted in a decrease of basal level of plasma testosterone (P < 0.01). In addition, basal testosterone and pregnenolone release by Leydig cells prepared from maneb 18-day treated animals were significantly reduced (P < 0.05). However, acute in vitro exposure of TIC or Leydig cells to maneb did not alter their testosterone release. These results suggested that maneb alters testosterone production, at least in part, through inhibition of CYP11A1 activitiy.
Insights
Maneb fungicide exposure in rats reduced testosterone production by inhibiting Leydig cell activity. This fungicide may impact male reproductive function by affecting key enzymes in steroidogenesis.
Area of Science:
- Toxicology
- Reproductive Toxicology
- Endocrinology
Background:
- Maneb (Manganese ethylene-bis-dithiocarbamate) is a widely used agricultural fungicide.
- Concerns exist regarding its potential impact on male reproductive health.
Purpose of the Study:
- To investigate the effects of maneb exposure on male rat reproductive function.
- To determine if maneb affects testosterone production and Leydig cell activity.
Main Methods:
- Rats were injected with maneb (1 and 4 mg/kg) for 9 or 18 days.
- Hormonal profiles and organ weights were assessed; Leydig cells were isolated and stimulated in vitro.
- In vitro studies exposed Leydig cells and testicular interstitial cells (TICs) to maneb.
Main Results:
- Maneb (4 mg/kg) decreased plasma testosterone levels and reduced basal testosterone and pregnenolone release from Leydig cells.
- Liver function and organ weights remained largely unaffected.
- In vitro exposure of Leydig cells and TICs to maneb did not alter testosterone release.
Conclusions:
- Maneb exposure in vivo alters testosterone production, potentially by inhibiting CYP11A1 activity.
- The fungicide's effects appear to be mediated through chronic exposure rather than acute in vitro contact.
- Maneb may negatively impact male reproductive function through disruption of steroidogenesis.
